Transactions 2020 | Health
June 3, 2020 New York New York
Be it a strategic merger or financial acquisition, the healthcare industry has experienced record-setting deal volume over the last few years. Given transactions within the pharma and biotech space to disruptions in healthcare services, we continue to see financial sponsors seeking out new paths to grow. While some believe the pace of consolidation will increase, others wonder if pricing has become too expensive and appetites for deals, overly exuberant. So is now the time to buy, sell or go public? At DirectorCorps’ annual Transactions Conference, we explore these potential paths with top executives and members of the boards of leading healthcare organizations.